Difficulty with urination from an enlarged prostate is probably the most frequent symptom I see in my clinic. An enlarged prostate can significantly reduce a patient’s quality of life. Until recently, the only options available were medications to shrink the prostate such as tamsulosin or finasteride or surgery such as a transurethral resection of the prostate (sometimes referred to as a “roto-rooter”). Recently two new minimally invasive options have become available. These include the Urolift and the Rezum. Both are less invasive options to open the prostatic channel with the potential to decrease symptoms. While the long term duration of these treatments remains unknown, I intend to watch the data closely to see if this technology should become standard of care or not.